Mixed gangliocytoma-pituitary adenoma of dual lineage: A case report

IF 0.4 Q4 CLINICAL NEUROLOGY
Sarah Obiedat , Karol Silla , Caterina Giannini , Issam Al Bozom , Ali Ayyad
{"title":"Mixed gangliocytoma-pituitary adenoma of dual lineage: A case report","authors":"Sarah Obiedat ,&nbsp;Karol Silla ,&nbsp;Caterina Giannini ,&nbsp;Issam Al Bozom ,&nbsp;Ali Ayyad","doi":"10.1016/j.inat.2023.101933","DOIUrl":null,"url":null,"abstract":"<div><p>Worldwide, the simultaneous occurrence of sellar gangliocytoma with pituitary adenoma is rarely reported. Herein, we describe a unique case of mixed gangliocytoma-pituitary adenoma of dual lineage. A 45-year-old male presented with transient ischemic attack, right sided numbness and decreased vision. Endocrinological examination found prolactin level to be elevated. Imaging studies revealed a 2.8 cm sellar/suprasellar lesion with superior displacement of optic chiasm. The patient underwent tumor resection via endoscopic endonasal transsphenoidal approach. Histologic sections show a biphasic tumor with two populations of cells, mature ganglion cells and prolactin secreting neuroendocrine cells. The tumor has unique dual lineage with one dominant expression of pituitary-specific transcription factor (PIT1) in all cell components which matched closely to prolactin positivity. By Immunohistochemistry, a less prominent but obvious component of scattered steroidogenic factor 1 (SF1) positive cells were identified, although follicle stimulating hormone (FSH) and luteinizing hormone (LH) were negative. T-box transcription factor (TPIT) stain was negative. Accordingly, the diagnosis of mixed gangliocytoma-pituitary adenoma of dual lineage was established.</p></div>","PeriodicalId":38138,"journal":{"name":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","volume":"36 ","pages":"Article 101933"},"PeriodicalIF":0.4000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214751923002165/pdfft?md5=dc3ef23096977723ec683b0fb9997ab1&pid=1-s2.0-S2214751923002165-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214751923002165","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Worldwide, the simultaneous occurrence of sellar gangliocytoma with pituitary adenoma is rarely reported. Herein, we describe a unique case of mixed gangliocytoma-pituitary adenoma of dual lineage. A 45-year-old male presented with transient ischemic attack, right sided numbness and decreased vision. Endocrinological examination found prolactin level to be elevated. Imaging studies revealed a 2.8 cm sellar/suprasellar lesion with superior displacement of optic chiasm. The patient underwent tumor resection via endoscopic endonasal transsphenoidal approach. Histologic sections show a biphasic tumor with two populations of cells, mature ganglion cells and prolactin secreting neuroendocrine cells. The tumor has unique dual lineage with one dominant expression of pituitary-specific transcription factor (PIT1) in all cell components which matched closely to prolactin positivity. By Immunohistochemistry, a less prominent but obvious component of scattered steroidogenic factor 1 (SF1) positive cells were identified, although follicle stimulating hormone (FSH) and luteinizing hormone (LH) were negative. T-box transcription factor (TPIT) stain was negative. Accordingly, the diagnosis of mixed gangliocytoma-pituitary adenoma of dual lineage was established.

双系混合性神经节细胞瘤-垂体腺瘤:病例报告
在世界范围内,同时出现蝶鞍神经节细胞瘤和垂体腺瘤的报道很少。在此,我们描述了一例独特的神经节细胞瘤-垂体腺瘤双系混合瘤病例。一名 45 岁的男性因短暂性脑缺血发作、右侧麻木和视力下降就诊。内分泌检查发现泌乳素水平升高。影像学检查发现,蝶鞍/鞍上病变长 2.8 厘米,视丘上移。患者通过内窥镜经鼻蝶窦途径接受了肿瘤切除术。组织学切片显示,该肿瘤为双相肿瘤,有两种细胞群,即成熟的神经节细胞和分泌催乳素的神经内分泌细胞。肿瘤具有独特的双系性,垂体特异性转录因子(PIT1)在所有细胞成分中均呈显性表达,与催乳素阳性密切相关。免疫组化结果显示,尽管促卵泡激素(FSH)和促黄体生成素(LH)呈阴性,但仍发现了不太突出但明显的散在类固醇生成因子 1(SF1)阳性细胞。T-盒转录因子(TPIT)染色呈阴性。因此,神经节细胞瘤-垂体腺瘤双系混合瘤的诊断成立。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
236
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信